XiFin Lab Volume Index Presents Timely Picture of Testing Volumes
The XiFin LVI data is a near-real-time look at routine and COVID testing volumes across the US. Its synthesis of diagnostic data enables cross-specialty comparisons of the routine lab, COVID-19 PCR, and antibody testing. The COVID virus's continued presence has a lasting impact on both COVID and routine testing. Access our interactive Laboratory Volume Index charts to see the latest.
Featured Insights
NEWS
XiFin's Revenue Cycle Management (RCM) Voted #1 Client Rated Solution by Diagnostic Labs
EVENT
A CFO's guide to boosting profitability and leveraging outpatient, outreach, and ancillary services to reduce overall costs while improving quality with revenue cycle automation and advanced analytics.
WHITE PAPER
To effectively manage complex business decisions and optimize clinical outcomes, diagnostic service providers must be able to precisely measure results and compare them to internal goals and industry benchmarks.
Industry Segments
XiFin processes over $40B in claims/tests annually for a growing number of key healthcare diagnostics segments.
Success Stories
See how all types of diagnostics providers are using XiFin to gain control over RCM and improve performance.
Proven Success
Join the next generation in revenue cycle management.
0%
8% Average First Year Improvement in Net Cash Collection, Adjusted for Growth
0M
120+ Million Accessions/Visits Processed Annually
0%
100% Payor Reach
0%
50% Reduction in Denials
0X
Threefold Increase in Successful Appeals
Let's Get the Conversation Started
If you’re ready to find out how we can help you improve visibility, control, and profitability, contact us and we’ll be in touch right away.